Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Gorini

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
International Journal of Pharmaceutics|July 28, 2025
Hierarchical paclitaxel encapsulation in microbead-embedded microparticles for sustained ovarian cancer therapyCristina Chirizzi, Francesca Gorini, Ilaria Porello, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case-Control Study in Salento (Southern Italy)Fabrizio Minichilli, Francesca Gorini, Giovanni De Filippis, et al.
Cell Reports|March 15, 2018
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer ProgressionFilippo Cortesi, Gloria Delfanti, Andrea Grilli, et al.
European Journal of Pediatrics|March 3, 2023
Prescriptions for insulin and insulin analogues in children with and without major congenital anomalies: a data linkage cohort study across six European regionsJoanne Given, Joan K Morris, Ester Garne, et al.
Life (Basel, Switzerland)|February 27, 2026
Dercum's Disease: Bridging Present Understanding and Emerging DirectionsFrancesca Gorini, Alessio Coi, Alice Verdelli, et al.
Cancer Research|October 19, 2023
Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung CancerJudith Mary Hariprakash, Elisa Salviato, Federica La Mastra, et al.
Frontiers in Oncology|November 22, 2021
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial CancerGloria Ravegnini, Antonio De Leo, Camelia Coada, et al.
Life (Basel, Switzerland)|May 4, 2026
Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment-A Single Center Case SeriesAlessandro Magnatta, Alice Verdelli, Virginia Corti, et al.
Scientific Reports|November 21, 2025
MiRNome alterations drive the malignant transformation of endometriosis into endometriosis-correlated ovarian cancerCamelia Alexandra Coada, Anna Myriam Perrone, Francesca Gorini, et al.
Cancer Science|January 10, 2024
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapyGloria Ravegnini, Francesca Gorini, Camelia Alexandra Coada, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
International Journal of Pharmaceutics|July 28, 2025
Hierarchical paclitaxel encapsulation in microbead-embedded microparticles for sustained ovarian cancer therapyCristina Chirizzi, Francesca Gorini, Ilaria Porello, et al.
International Journal of Environmental Research and Public Health|July 27, 2022
Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case-Control Study in Salento (Southern Italy)Fabrizio Minichilli, Francesca Gorini, Giovanni De Filippis, et al.
Cell Reports|March 15, 2018
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer ProgressionFilippo Cortesi, Gloria Delfanti, Andrea Grilli, et al.
European Journal of Pediatrics|March 3, 2023
Prescriptions for insulin and insulin analogues in children with and without major congenital anomalies: a data linkage cohort study across six European regionsJoanne Given, Joan K Morris, Ester Garne, et al.
Life (Basel, Switzerland)|February 27, 2026
Dercum's Disease: Bridging Present Understanding and Emerging DirectionsFrancesca Gorini, Alessio Coi, Alice Verdelli, et al.
Cancer Research|October 19, 2023
Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung CancerJudith Mary Hariprakash, Elisa Salviato, Federica La Mastra, et al.
Frontiers in Oncology|November 22, 2021
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial CancerGloria Ravegnini, Antonio De Leo, Camelia Coada, et al.
Life (Basel, Switzerland)|May 4, 2026
Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment-A Single Center Case SeriesAlessandro Magnatta, Alice Verdelli, Virginia Corti, et al.
Scientific Reports|November 21, 2025
MiRNome alterations drive the malignant transformation of endometriosis into endometriosis-correlated ovarian cancerCamelia Alexandra Coada, Anna Myriam Perrone, Francesca Gorini, et al.
Cancer Science|January 10, 2024
miRNA levels are associated with body mass index in endometrial cancer and may have implications for therapyGloria Ravegnini, Francesca Gorini, Camelia Alexandra Coada, et al.
Pageof 10